"Lignocaine vs GTN Ointment for Postoperative Pain After Hemorrhoidectomy")
Role of Topical Application of Lignocaine Versus 0.2% Glyceryl Trinitrate (GTN) Ointment as a Postoperative Local Analgesic in Hemorrhoidectomy in Terms of Pain Score,Wound Healing Time and Patient Satisfaction Level
1 other identifier
interventional
64
1 country
1
Brief Summary
This study is being conducted at the Department of General Surgery, King Edward Medical University, Lahore, Pakistan. The purpose of the trial is to compare the effectiveness of topical Lignocaine ointment versus topical Glyceryl Trinitrate (GTN) ointment in reducing postoperative pain following hemorrhoidectomy. Patients undergoing hemorrhoidectomy will be randomly assigned to receive either Lignocaine ointment or GTN ointment applied locally after surgery. Pain relief will be assessed using a visual analog scale (VAS) at regular intervals during the postoperative period. The study aims to determine which ointment provides better pain control and improves patient comfort during recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 2, 2025
CompletedFirst Submitted
Initial submission to the registry
August 21, 2025
CompletedFirst Posted
Study publicly available on registry
September 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedSeptember 8, 2025
September 1, 2025
4 months
August 21, 2025
September 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postoperative pain score
Pain intensity will be assessed using the Visual Analogue Scale (VAS), which ranges from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain severity.
Up to 1 month postoperatively.
Wound Healing Time
Defined as the number of days from the date of surgery until complete wound healing (full epithelialization with no discharge or open area). Shorter duration indicates a better outcome.
Up to 1 month postoperatively.
Secondary Outcomes (7)
patient Satisfaction Level
6 weeks postoperatively
Time to Request of First Analgesic Dose
Within 24 hours postoperatively
Amount of Analgesia Administered in First 24 Hours
0-24 hours postoperatively
Incidence of Wound Secretion
1 month postoperatively
Incidence of Itching
1 month postoperatively
- +2 more secondary outcomes
Study Arms (2)
1.Lignocaine Ointment Group
EXPERIMENTALParticipants will receive topical lignocaine ointment applied to the anal wound post-hemorrhoidectomy for pain control.
Glyceryl Trinitrate Ointment Group
EXPERIMENTALParticipants will receive topical 0.2% glyceryl trinitrate ointment applied to the anal wound post-hemorrhoidectomy for pain control.
Interventions
Applied to the anal wound three time daily after hemorrhoidectomy.
Applied to the anal wound three time daily after hemorrhoidectomy.
Eligibility Criteria
You may qualify if:
- Age between 18 - 60 years
- Both genders
- Grade III and IV hemorrhoids diagnosed on the basis of history and clinical examination by consultant Surgeon.(Grade III Hemorrhoid manually reduced by patient with finger and Grade IV is prolapsed)
- ASA (American society of Anesthesia) grades I, and II
You may not qualify if:
- Previously reported allergy or reaction to lignocaine and GTN
- Pregnancy or lactation
- Concomitant perianal pathology warranting surgery
- Cardiovascular disease
- Patient taking Nitrates or Calcium channel blocker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King Edward Medical uUniveristy Mayo Hospital
Lahore, Punjab Province, 54000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hafiz Ahmad Rauf
King Edward Medical University/Mayo hospital Lahore
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2025
First Posted
September 8, 2025
Study Start
August 2, 2025
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
September 8, 2025
Record last verified: 2025-09